The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer
IUBMB Life · 2024-12 · 76 (12) · 1050-1057
DOI: 10.1002/iub.2908 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift IUBMB Life, online erschienen am 12.08.2024. Verfasst von Siyuan Zuo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colorectal Neoplasms, Immunotherapy, Probiotics. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Key Project in Natural Science Research in Higher Education Institutions of Anhui Province, Key Project of Natural Science Foundation of Wannan Medical College, Key Research Project of Wuhu Municipal Health Commission.
Abstract (Originalsprache)
This systematic literature review and meta‐analysis provide an overview of the critical role of gut microbiota in modulating the efficacy of immunotherapy for colorectal cancer. Gut microbes influence host immune responses through multiple mechanisms including modulation of immune cell activity, metabolite action, and immune tolerance. The ability of specific gut microbes to improve the efficacy of immune checkpoint inhibitors has been linked to their ability to improve gut barrier function, modulate immune cell activity, and produce key immunomodulatory metabolites such as short‐chain fatty acids. In addition, the composition and diversity of the gut microbiota are strongly associated with the efficacy of immunotherapies, demonstrating the potential to improve therapeutic response by modifying the gut microbiota. This paper also discusses the prospect of manipulating the gut microbiota through strategies such as fecal microbial transplantation, probiotic supplementation, and dietary modifications to optimize the efficacy of immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China.
- School of Clinical Medicine, Wannan Medical College, Wuhu, Anhui, China.
ORCID-Profile: Junwei Zou
Förderung
- Key Project in Natural Science Research in Higher Education Institutions of Anhui Province
- Key Project of Natural Science Foundation of Wannan Medical College
- Key Research Project of Wuhu Municipal Health Commission
- Climbing Scientific Peak Project for Talents, the Second Affiliated Hospital of Wannan Medical College
Zitieren
APA
Zuo, S., Huang, Y., & Zou, J. (2024). The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer. IUBMB Life, 76(12), 1050-1057. https://doi.org/10.1002/iub.2908
Vancouver
Zuo S, Huang Y, Zou J. The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer. IUBMB Life. 2024;76(12):1050-1057. doi:10.1002/iub.2908
BibTeX
@article{Zuo2024,
author = {Zuo, Siyuan and Huang, Yong and Zou, Junwei},
title = {The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer},
journal = {IUBMB Life},
year = {2024},
volume = {76},
number = {12},
pages = {1050--1057},
doi = {10.1002/iub.2908}
}
EUVIMED